Variables affecting outcomes after allogeneic hematopoietic stem cell transplant for cerebral adrenoleukodystrophyRobert Chiesa, Paul J. Orchard, Elizabeth McNeil et al.|Blood Advances|2021Cited by 40
The Development of New Agents for Post-Hematopoietic Stem Cell Transplantation Non-Infectious Complications in ChildrenUri Ilan, Francisco Bautista, Erica Brivio et al.|Journal of Clinical Medicine|2023Cited by 6
Second‐line treatment for acute graft‐versus‐host disease with mesenchymal stromal cells: A decision modelFrederick W. Thielen, Carin A. Uyl‐de Groot, Hedwig M. Blommestein et al.|European Journal Of Haematology|2018Cited by 6
Durable Clinical Benefits with Exagamglogene Autotemcel for Transfusion-Dependent β-ThalassemiaFranco Locatelli, Haydar Frangoul, Peter Lang et al.|Blood|2024Cited by 4
Improvements in health-related quality of life in patients with transfusion-dependent β-thalassemia after exagamglogene autotemcelJosu de la Fuente, Franco Locatelli, Haydar Frangoul et al.|Blood Advances|2025Cited by 3